Sept 29 (Reuters) – Metsera Inc: * METSERA REPORTS POSITIVE PHASE 2B RESULTS FOR FIRST- AND BEST-IN-CLASS ULTRA-LONG ACTING GLP-1 RA CANDIDATE MET-097I, ENABLING RAPID TRANSITION INTO PHASE 3 * METSERA INC – MET-097I SHOWS 14.1% WEIGHT LOSS AFTER 28 WEEKS * METSERA INC – MET-097I SHOWS CLASS-LEADING TOLERABILITY IN TRIALS * METSERA INC – DATA SUPPORTS PHASE 3 INITIATION IN LATE 2025 Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Jasper Ward WASHINGTON, June 26 (Reuters) - The United States has seized nearly 400…
By Jasper Ward WASHINGTON, June 26 (Reuters) - The United States has seized nearly 400…
By Jasper Ward WASHINGTON, June 26 (Reuters) - The United States has seized nearly 400…
Berlin (dpa) - People react differently to heat, with some fine even as temperatures soar,…
Mumbai (Maharashtra) [India], June 26: In a significant move aimed at strengthening environmental governance and…
Jamshedpur (Jharkhand) [India], June 26: XLRI – Xavier School of Management has been awarded the…